ArticleBMC endocrine disorders2025

Risk factors and outcomes of thyroid immune-related adverse events following PD-1/PD-L1 inhibitors treatment in a large tertiary Chinese center.

Wenwen Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.